ArticleDiabetes, metabolic syndrome and obesity : targets and therapy2022

Development of a Measure to Assess Attitudes Towards Nasal versus Autoinjector Glucagon Delivery Devices for Treatment of Severe Hypoglycemia.

Sanjay K Bajpai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.